Prospective isolation of HSCs requires that the isolated cells are capable of long-term production of all blood cell types in primary irradiated hosts, as well as self-renewal, such that the cells can be transplanted to secondary hosts to give rise to long-term multilineage repopulation. From the first enrichment and isolation of candidate HSCs 1,9,10
, this activity has been entirely contained in cell-surface-marker-defined cell populations, and more recently in fluorescent reporters [11] [12] [13] . However, the precise fraction of cells in those populations that are true LT-HSCs remains unknown.
To enable further purification of LT-HSCs, we sought to identify genes expressed exclusively in HSCs within cell populations resident in mouse bone marrow, detectable by flow cytometry and in situ fluorescence, and thus performed the following four-step screening (Fig. 1d) .
First, we compared microarray gene expression assays among 28 distinct populations of the haematopoietic system (Extended Data Fig. 1a and Supplementary Table 1 ). Using the Gene Expression Commons platform 14 , we identified 118 candidate HSC-specific genes (Fig. 1a and  Supplementary Table 2) . Surprisingly, this list did not include all previously reported HSC-specific markers [11] [12] [13] (Extended Data Fig. 1b and  Supplementary Table 2) . Second, to identify HSCs in situ, we excluded candidates that also label non-haematopoietic cells present in the bone marrow such as stromal and endothelial cells 15, 16 . Consequently, we excluded genes expressed in eight distinct non-haematopoietic bone marrow populations, thereby narrowing the list to 45 candidate genes (Fig. 1a) .
Next, to ensure that the expression of any candidates could be detected by both flow cytometry and in situ fluorescence, we used RNAsequencing (RNA-seq) combined with a threshold gene standard to estimate the fragments per kilobase of transcript per million mapped reads (FPKM) value that could serve as a detection threshold. From the bone marrow of 12-week-old mice, we sorted and RNA-sequenced immunophenotypically defined (Lin − c-Kit (Fig. 1b) to determine the FPKM value of candidate genes. On the basis of Bmi-1-eGFP knock-in reporter expression 17 , we found that a single copy of eGFP is detectable at an estimated FPKM value of ~ 20. However, this high threshold would have excluded all candidate genes. Therefore, we designed a targeting construct ( Fig. 1e ) with three copies of mCherry, bringing the theoretical detection limit to ~ 7 FPKM. Lastly, to minimize aberrant detection, we set threshold FPKM values for both the MPPa and MPPb fractions to 2.5. Only three genes, Hoxb5, Rnf208, and Smtnl1, met these criteria (Fig. 1b) .
Given previous reports of heterogeneity within pHSCs 7, [18] [19] [20] , we analysed single cells to determine whether the remaining candidate genes were heterogenously expressed among pHSCs. We reasoned that an ideal pan-HSC candidate gene would label the majority of pHSCs, with quantitative differences potentially reflecting HSC heterogeneity/diversity. We thus performed single-cell quantitative PCR (qPCR) analysis of pHSCs, and evaluated expression of Hoxb5, Rnf208, and Smtnl1. Only Hoxb5 exhibited bimodal expression, in comparison to the unimodality of Rnf208 and Smtnl1 (Fig. 1c) . Therefore, from the entire HSC transcriptome, only Hoxb5 satisfied the criteria of our extensive unbiased screening (Fig. 1d) .
We next sought to generate a Hoxb5 reporter with minimal disruption of endogenous Hoxb5 function. Thus we designed our targeting construct and CRISPR guide sequences to facilitate an in-frame knock-in to the endogenous Hoxb5 gene locus immediately 5′ of the only endogenous stop codon. We used three tandem mCherry cassettes separated by porcine teschovirus-1 2A (P2A) sequences, with the terminal mCherry carrying a CAAX membrane localization sequence (Hoxb5-tri-mCherry) (Fig. 1e) .
To evaluate the specificity of this reporter, we isolated whole bone marrow cells from 12-week-old reporter mice and measured mCherry + cells in the following immunophenotypic populations: pHSC, MPPa, MPPb, Flk2
+ multipotent progenitor, megakaryocyte erythrocyte progenitor, granulocyte monocyte progenitor, common myeloid progenitor, common lymphoid progenitor fractions; differentiated cell populations (B cell, T cell, natural killer (NK) cell, neutrophil, eosinophil, monocyte, macrophage, dendritic cell, red blood cell, and megakaryocyte); and in CD45 − stromal fractions (Fig. 1f , Extended Data Fig. 2a, b, Extended Data Fig. 3 , and unpublished data). Consistent with our initial screen (Fig. 1a-d) , and using wild-type mice as a fluorescence minus one (FMO) threshold 21 , mCherry-labelled cells were highly enriched in the pHSC fraction (21.8% ± 0.90%), had a low Letter reSeArCH frequency in the MPPa fraction (1.88% ± 0.64%), and background frequencies in the remaining fractions (Fig. 1f , Extended Data Figs 2b and 3 and unpublished data). Interestingly, as only a minority of pHSCs were mCherry + , this suggested that either our reporter labelled only a subfraction of HSCs or only a subfraction of pHSCs were indeed HSCs.
To distinguish between these two possibilities and to determine whether Hoxb5 is a reporter of LT-HSCs, we characterized Hoxb5-expressing cells by transplantation. In order to be inclusive of all events in the pHSC gate, we used wild-type FMO to define Hoxb5 negativity (Hoxb5 neg or sometimes referred to as Hox5 Fig. 5a ). Three-cell transplants exhibited similar kinetics (Extended Data Fig. 5c) . Notably, the chimaerism of the Hoxb5 neg pHSCs decreased over time, in particular between 4 to 8 weeks and shifted towards a predominantly lymphoid chimaerism (Fig. 2b, d and Extended Data Fig. 5a ), suggesting that either the hi recipients and transplanted them into irradiated secondary recipients (n = 24 mice) (Fig. 2a) . As with the primary bone marrow transplantations, the chimaerism was minimal in Hoxb5 − compared to Hoxb5 + recipients (Extended Data Fig. 5d ). Limiting dilution analysis revealed that the frequency of long-term plus short-term HSCs in primary Given that Hoxb5 − cells are non-LT-HSCs, we re-examined the specificity of past definitions (Fig. 3a, f) , including previously reported refinements to the LT-HSC immunophenotype [18] [19] [20] and the most widely used in situ definition over the past decade 22 . We found that 78.5% ± 2.6% of CD11a − HSCs 19 , 63.9% ± 3% of the HSC-1 (Lin − c-Kit
, and 82.5% ± 0.4% of fraction I HSCs (Lin (Fig. 3e ). As this subset was initially used for localization of HSCs in situ 22 , we re-examined the in situ location of HSCs using Hoxb5 expression.
Visualizing LT-HSCs in bone marrow and identifying the cellular constituents and structures of the HSC niche remains challenging. Despite this, multiple constituent cell types have been proposed, including mesenchymal stromata, endosteal osteoblasts, glia, endothelia, and pericytes
5
. In situ studies are made difficult by several technical limitations, including the number of fluorescent colours, difficulty in identifying HSCs surrounded by non-HSCs, and difficulty in translating the same fluorescently defined positive and negative thresholds from flow cytometry to tissue sections.
To address these issues, we used the Hoxb5-tri-mCherry reporter. Using flow cytometry, we determined the utility of Hoxb5 alone in identifying LT-HSCs. After logical exclusion of autofluorescence by comparison to wild-type control mice, we found that all Hoxb5 + events are within the c-Kit + fraction and 62.0 ± 12.8% of all Hoxb5 + events are located in the pHSC gate (Extended Data Fig. 8) , representing an eight-to nine-fold enrichment compared to previous in situ labelling of HSCs (Lin 22 ( Fig. 3e) . To reveal the three-dimensional (3D) HSC niche architecture, we applied the CUBIC technique (clear, unobstructed brain imaging cocktails and computational analysis 23 ) to tibial bone marrow, facilitating depletion of autofluorescent cellular components (Fig. 4a) . Given Fig. 7a-d for gating scheme) .
Letter reSeArCH that fluorescence intensity is preserved by CUBIC 23 , the specificity of LT-HSCs in situ correlates with Hoxb5 intensity determined by flow cytometry. Therefore, on the basis of the number of Hoxb5
+ LT-HSCs detected in one tibia (Extended Data Fig. 9a, b) , we objectively gated the same number of Hoxb5 + cells by intensity as in situ Hoxb5 + cells. We observed a uniform distribution of in situ Hoxb5
+ cells along the longitudinal axis of the tibia (Fig. 4e and Extended Data Fig. 10a-c) . (Fig. 4e) . To investigate the association of LT-HSCs with vasculature, we injected anti-mouse VE-cadherin antibody into reporter mice and analysed the bone marrow with CUBIC 23 . We found that 94.1 ± 1.9% of in situ Hoxb5 + cells were directly attached to the abluminal surface of VE-cadherin + endothelial cells. In contrast, only 52.8 ± 2.3% of the random (Hoxb5 − ) spots were directly associated with VE-cadherin + cells. This implied a near-homogenous perivascular location for the LT-HSC niche (Fig. 4b-d) .
Following the first successful enrichment of HSCs in 1988 (ref. 1), many groups have attempted to identify surface markers to isolate LTHSCs [18] [19] [20] 22, 24, 25 . Identification of CD150, CD34, and CD48 enabled isolation of LT/ST-HSCs from MPPs. However, complete separation of LT-HSCs from ST-HSCs has never been fully accomplished. Our study demonstrates that Hoxb5 expression is specifically limited to LT-HSCs in adult mouse bone marrow. Limiting dilution assay shows that at least 1 in 2.1 of Hoxb5 hi cells are LT-HSCs. However, this assay underestimates the functional potential of candidate HSCs. Transplantation, although the gold standard for prospective isolation of HSCs, may not take into account differences between sessile and mobile HSCs 26, 27 , cell cycle status 28, 29 , expression of CD47 (an anti-phagocytic molecule expressed highly on mobilized HSCs but at low levels on sessile bone marrow HSCs , it is likely that our results differ owing to the fraction of assayed populations that are LT-HSCs (Extended Data Fig. 1b and Supplementary Table 3) . These results suggest that the model of Hoxb5-tri-mCherry is the most specific available, to our knowledge, for identification of LT-HSCs, and could facilitate in situ lineage tracing to define their role in haematopoiesis in the absence of transplantation into irradiated hosts.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. + cells (n = 287 cells, from n = 3 mice) and random spots (n = 600 spots, from n = 3 mice) plotted against proximity to VE-cadherin + cells. * * * P < 0.0001. e, Average number of Hoxb5 + cells in proximal, medial, and distal regions of tibia (n = 3 mice). NS, not significant. Unpaired Student's t-test (d, e).
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Data Reporting. No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to outcome assessment. Mice. Eight-to-twelve-week-old C57BL/6J male mice (Jackson Laboratory) were used as wild-type controls. Eight-to-twelve-week-old male B6.SJL- ). Mice were bred at our animal facility according to NIH guidelines. All animal protocols were approved by the Stanford University Administrative Panel on Laboratory Animal Care. Hoxb5-tri-mCherry (C57BL/6J background) mice were used as donor cells for transplantation as well as for analysis. Please see Gene targeting for mouse derivation. Microarray data. All microarray data employed in this study are available at Gene Expression Commons (http://gexc.stanford.edu) and GEO GSE77078. Two to four microarray replicates were assessed for each distinct cell population [14] [15] [16] . The immunophenotype definition of each fraction is included in Supplementary Table 1 . RNA sequencing. RNA sequencing was performed as previously described 31 . In brief, total RNA was isolated with trizol, treated with RQ1 RNase free DNase (Promega) to remove minute quantities of genomic DNA if present, and cleaned up using RNeasy minelute columns (QIAGEN). cDNA libraries were prepared for pHSC, MPPa, and MPPb populations using Ovation RNA-Seq System V2 (NuGen) and sequenced separately using HiSeq 2500 (Illumina) to obtain 2 × 150 base pair (bp) paired-end reads. Raw transcriptome sequence data were mapped to Mus musculus reference mRNAs using OLego 32 to produce a reference-guided transcript assembly. Four replicates were sequenced for each population. Data are accessible at NCBI SRP068593. Single-cell qPCR. Single cells for qPCR were processed using the Single Cell-to-CT qRT-PCR Kit (Life Technologies) as per the manufacturer's instructions. Cells were sorted directly into lysis solution in a 96-well plate, subjected to a reverse transcription reaction for cDNA synthesis, amplified for 14 cycles with pooled TaqMan Gene Expression Assays, and diluted with 1× TE buffer (pH 8.0). For real-time PCR, samples were amplified for 50 cycles of 3 s at 95 °C followed by 30 s at 60 °C using the following TaqMan probes: Mm00657672_m1 for Hoxb5; Mm03039759_s1 for Rnf208; Mm00470338_m1 for Smtnl1; and Mm99999915_g1 for Gapdh. All thermocycling was performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems). Presence of a single cell was validated by a C t value of 30 or less for Gapdh. Gene targeting. The targeting construct was cloned into pJYC (derived from pUC19, golden gate insert of TALE backbone vector 33 , and removal of LacZ sequence). Right and left homology arms of ~ 700 bp were cloned by PCR from C57BL/6J genomic DNA, and the entire construct was sequence validated. BRUCE-4 embryonic stem (ES) cells (Millipore) derived from C57BL/6J mice were transfected with the targeting construct as well as bicistronic CRISPR vector PX330 expressing Cas9 and a Hoxb5-specific single guide RNA (5′ -GGCUCCUCCGGAUGGGCUCA-3′ ) 34 . Following homologous recombination, recombinant clones were positively selected for one week with neomycin (100 μ g ml −1
), transfected with an EF1α -Cre-puromycin vector, and selected for a second week with puromycin (1 μ g ml
−1
). Serially diluted ES colonies were then individually picked, expanded, and screened by PCR and qPCR for site-specific integration, exclusion of off-target effects, and correct copy number. After sequence validation of the targeted site, successfully targeted ES clones were used to establish chimaeras. Chimaeric mice were crossed with C57BL/6 − Tyr c-2j /J female mice to establish germline transmission. Flow cytometry and cell sorting. Flow cytometry and cell sorting were performed on a FACS Aria II cell sorter (BD Biosciences) and analysed using FlowJo software (Tree Star). Bone marrow cells were collected from bilateral tibias, femurs, humeri, and pelvises by crushing (unless otherwise specified) using a mortar and pestle in Ca 2+ -and Mg
2+
-free PBS supplemented with 2% heat-inactivated bovine serum (Gibco) and 2 mM EDTA. Cells were passed through 100 μ m, 70 μ m, and 40 μ m strainers before analysis and sorting. To enrich HSCs and progenitor populations, cells were stained with APC-conjugated anti-c-Kit (2B8) and fractionated using anti-APC magnetic beads and LS columns (both Miltenyi Biotec). c-Kit + cells were then stained with combinations of antibodies against the following surface markers: Sca-1, Flk2, CD150, CD34, IL-7R, CD16/32, and the lineage markers Ter-119, B220, CD2, CD3, CD4, CD5, CD8a, Gr-1, CD11a, CD11b, CD41, CD48, CD229, and CD244. For lymphoid populations, bone marrow cells were stained with antibodies against CD3, CD4, CD8a, CD11b, CD11c, Gr-1, NK-1.1, Ter-119, B220, c-Kit, and F4/80. For myeloid populations, cells were stained with antibodies against CD3, CD3-, CD11b, CD11c, CD19, Gr-1, NK-1.1, Ter-119, and F4/80. Antibody staining was performed at 4 °C and cells were incubated for 30 min. Cells stained with CD34 were incubated for 90 min. Before sorting or analysis, cells were stained with SYTOX Red Dead Cell Stain (Life Technologies) to assess viability as per the manufacturer's recommendations. Transplanted cells were double-sorted for purity. Further details regarding flow cytometry reagents are provided in Supplementary , and 16 weeks after primary and secondary transplantations. At each time point, 50 μ l of blood was collected from the tail vein and added to 100 μ l of PBS with 2 mM EDTA. Red blood cells were subsequently lysed using BD Pharm Lyse Buffer (BD Pharmingen), as per the manufacturer's protocol, for 3 min on ice, followed by blocking with 5 μ g ml −1 rat IgG. Leukocytes were stained with antibodies against (refer to Supplementary Table 4 for specific clones and colours): CD45.1 (FITC), CD45.2 (PE), CD11b (BUV395), Gr-1 (Alexa-Flour700), B220 (BV786), CD3 (BV421), TCRβ (BV421), and NK-1.1 (PerCP-cy5.5). For each mouse, the percentage of donor chimaerism in the peripheral blood was defined as the percentage of CD45. A nonlinear regression semi-log best fit line was used to calculate the frequency of LT/ST-HSCs at F 0 = 0.368 (GraphPad Prism 6). CUBIC bone marrow imaging. Bone clearing protocol was modified from the original CUBIC protocol 23 . Specifically, tibias were collected and fixed in 4% PFA solution for two days, after which bone marrow plugs were extracted from the distal end by flushing method with a 25-gauge syringe. For nuclear staining, bone marrow plugs were immersed in DAPI/PBS solution at 37 °C for three days with gentle shaking. For clearing, marrow plugs were immersed in ScaleCUBIC-1 (Reagent-1) at 37 °C for two weeks with gentle shaking. The solution was changed every 48 h. To visualize vasculature, 20 μ g of Alexa488-conjugated anti-mouse VE-cadherin antibody (BV13) was administrated intravenously (retro-orbital) with tibias collected 30 min later. Processed plugs were embedded in 4-mm-diameter glass capillaries with 2% agarose for imaging. Images were acquired using a Zeiss Z1 Lightsheet microscope (Zeiss) and reconstituted into 3D images using Zen software (Zeiss). Acquired 3D images were analysed with Imaris software (Bitplane). After exclusion of outliers including events of extraordinary size (> 30 μ m) or intensity, all other mCherry + (Hoxb5 + ) cells were analysed in the tibia (n = 287 cells in total from n = 3 mice). The mCherry-negative threshold was determined on the basis of the intensity level of the wild-type control tibial plugs. These mCherry − events with intensities ranging from 0.002-75.998 (75.998 representing the upper bound of mCherry intensity) were transformed into an integer list of 75,000 values (75,000 representing the length of the list), and 600 spots were then randomly selected from this integer list using the 'randbetween' (1,75,000) function in Excel 2015 (Microsoft). Using the list of random spots identified by intensity, the location and distance to VE-cadherin + cells was measured using the Imaris software. All CUBIC imaging experiments were performed in biological triplicates from three mice. Genotyping. Genomic DNA from Hoxb5-tri-mCherry mice was isolated from tail biopsies using QuickExtract solution (EpiCentre). PCR amplification was performed using the same forward primer (5′ -GACGTATCGAGATCGC CCAC-3′ ) with two reverse primers to distinguish between the Hoxb5-tri-mCherry (5′ -CCTTGGTCACCTTCAGCTTGG-3′ ) and wild-type (5′ -AGATTGGAAGGGTCGAGCTG-3′ ) alleles. Statistics. All comparative analyses were performed using unpaired Student's t tests. Pearson's chi-square test was performed using online software (http:// vassarstats.net/). 
